Point72 Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.12M	Buy	161,596 +100,130	+163%	+$772K	﹤0.01%	2700
2025 Q4	$542K	Buy	+61,466	New	+$338K	﹤0.01%	3195
2023 Q4	–	Sell	-57,490	Closed	-$248K	–	3001
2023 Q3	$248K	Buy	+57,490	New	+$319K	﹤0.01%	1710
2021 Q1	–	Sell	-170,000	Closed	-$2.23M	–	1219
2020 Q4	$2.23M	Buy	+170,000	New	+$2.05M	0.01%	713
2019 Q4	–	Sell	-223,375	Closed	-$2.97M	–	1293
2019 Q3	$2.97M	Buy	+223,375	New	+$3.11M	0.02%	538
2018 Q1	–	Sell	-125,000	Closed	-$1.9M	–	1181
2017 Q4	$1.9M	Buy	125,000 +25,000	+25%	+$371K	0.01%	746
2017 Q3	$1.79M	Sell	100,000 -1,842,400	-95%	-$30.8M	0.01%	694
2017 Q2	$31.7M	Sell	1,942,400 -542,100	-22%	-$7.81M	0.22%	152
2017 Q1	$34.8M	Buy	2,484,500 +2,333,400	+1,544%	+$33.3M	0.22%	138
2016 Q4	$2.41M	Sell	151,100 -391,600	-72%	-$6.29M	0.02%	540
2016 Q3	$9.03M	Buy	+542,700	New	+$7.31M	0.07%	299
2015 Q4	–	Sell	-1,900	Closed	-$21K	–	873
2015 Q3	$21K	Sell	1,900 -94,600	-98%	-$1.16M	﹤0.01%	727
2015 Q2	$1.23M	Buy	+96,500	New	+$1.04M	0.01%	601